168 related articles for article (PubMed ID: 8219665)
1. Treatment of pruritus: a new indication for serotonin type 3 receptor antagonists.
Schwörer H; Ramadori G
Clin Investig; 1993 Aug; 71(8):659-62. PubMed ID: 8219665
[TBL] [Abstract][Full Text] [Related]
2. Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron.
Schwörer H; Hartmann H; Ramadori G
Pain; 1995 Apr; 61(1):33-37. PubMed ID: 7644246
[TBL] [Abstract][Full Text] [Related]
3. Antipruritic effects of two different 5-HT3 receptor antagonists and an antihistamine in haemodialysis patients.
Weisshaar E; Dunker N; Röhl FW; Gollnick H
Exp Dermatol; 2004 May; 13(5):298-304. PubMed ID: 15140020
[TBL] [Abstract][Full Text] [Related]
4. Plasma serotonin and histamine levels in hemodialysis-related pruritus are not significantly influenced by 5-HT3 receptor blocker and antihistaminic therapy.
Weisshaar E; Dunker N; Domröse U; Neumann KH; Gollnick H
Clin Nephrol; 2003 Feb; 59(2):124-9. PubMed ID: 12608555
[TBL] [Abstract][Full Text] [Related]
5. Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients.
Balaskas EV; Bamihas GI; Karamouzis M; Voyiatzis G; Tourkantonis A
Nephron; 1998; 78(4):395-402. PubMed ID: 9578065
[TBL] [Abstract][Full Text] [Related]
6. The role of ondansetron in the management of cholestatic or uremic pruritus--a systematic review.
To TH; Clark K; Lam L; Shelby-James T; Currow DC
J Pain Symptom Manage; 2012 Nov; 44(5):725-30. PubMed ID: 22727254
[TBL] [Abstract][Full Text] [Related]
7. A controlled trial of ondansetron in the pruritus of cholestasis.
O'Donohue JW; Pereira SP; Ashdown AC; Haigh CG; Wilkinson JR; Williams R
Aliment Pharmacol Ther; 2005 Apr; 21(8):1041-5. PubMed ID: 15813840
[TBL] [Abstract][Full Text] [Related]
8. Ondansetron therapy for uremic pruritus in hemodialysis patients.
Ashmore SD; Jones CH; Newstead CG; Daly MJ; Chrystyn H
Am J Kidney Dis; 2000 May; 35(5):827-31. PubMed ID: 10793015
[TBL] [Abstract][Full Text] [Related]
9. Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial.
Müller C; Pongratz S; Pidlich J; Penner E; Kaider A; Schemper M; Raderer M; Scheithauer W; Ferenci P
Eur J Gastroenterol Hepatol; 1998 Oct; 10(10):865-70. PubMed ID: 9831410
[TBL] [Abstract][Full Text] [Related]
10. Ondansetron and pruritus in chronic liver disease: a controlled study.
Jones EA; Molenaar HA; Oosting J
Hepatogastroenterology; 2007 Jun; 54(76):1196-9. PubMed ID: 17629069
[TBL] [Abstract][Full Text] [Related]
11. Ondansetron for pruritus in child with chronic cholestasis.
Trioche P; Samuel D; Odièvre M; Labrune P
Eur J Pediatr; 1996 Nov; 155(11):990. PubMed ID: 8911904
[No Abstract] [Full Text] [Related]
12. Treatment of cholestatic itching in primary biliary cirrhosis with ondansetron.
Di Martino M; Galanti B; Nardiello S
Ital J Gastroenterol; 1995; 27(8):455. PubMed ID: 8775475
[No Abstract] [Full Text] [Related]
13. [Ondansetron for cholestatic pruritus].
Lamelo Alfonsín F; Vila Arias M; San Martín Moreira J; Silva César M
An Med Interna; 1998 Aug; 15(8):456. PubMed ID: 9780438
[No Abstract] [Full Text] [Related]
14. [Therapy of pruritus associated with skin diseases with the serotonin receptor antagonist ondansetron].
Zenker S; Schuh T; Degitz K
J Dtsch Dermatol Ges; 2003 Sep; 1(9):705-10. PubMed ID: 16285277
[TBL] [Abstract][Full Text] [Related]
15. Treatment of opioid-induced pruritus with ondansetron: report of four patients.
Larijani GE; Goldberg ME; Rogers KH
Pharmacotherapy; 1996; 16(5):958-60. PubMed ID: 8888093
[TBL] [Abstract][Full Text] [Related]
16. 5HT3 receptor antagonists and pruritus due to cholestasis.
Quigley C
Palliat Med; 1996 Jan; 10(1):54. PubMed ID: 8821191
[No Abstract] [Full Text] [Related]
17. Management of opioid-induced pruritus: a role for 5-HT3 antagonists?
Kyriakides K; Hussain SK; Hobbs GJ
Br J Anaesth; 1999 Mar; 82(3):439-41. PubMed ID: 10434832
[TBL] [Abstract][Full Text] [Related]
18. [Cholestatic pruritus--pathophysiology and therapy with special reference to treatment with 5-hydroxytryptamine subtype 3 receptor antagonists].
Schwörer H; Ramadori G
Z Gastroenterol; 1995 May; 33(5):265-74. PubMed ID: 7610695
[TBL] [Abstract][Full Text] [Related]
19. A randomized, placebo-controlled, double-blind trial of ondansetron in renal itch.
Murphy M; Reaich D; Pai P; Finn P; Carmichael AJ
Br J Dermatol; 2003 Feb; 148(2):314-7. PubMed ID: 12588385
[TBL] [Abstract][Full Text] [Related]
20. Ondansetron for paediatric uraemic pruritus: a case report.
Deshpande PV
Pediatr Nephrol; 2004 Jun; 19(6):694-6. PubMed ID: 15085422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
